813 related articles for article (PubMed ID: 8752281)
1. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B
Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281
[TBL] [Abstract][Full Text] [Related]
2. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.
Bleul CC; Farzan M; Choe H; Parolin C; Clark-Lewis I; Sodroski J; Springer TA
Nature; 1996 Aug; 382(6594):829-33. PubMed ID: 8752280
[TBL] [Abstract][Full Text] [Related]
3. Alternate splicing of mouse fusin/CXC chemokine receptor-4: stromal cell-derived factor-1alpha is a ligand for both CXC chemokine receptor-4 isoforms.
Heesen M; Berman MA; Höpken UE; Gerard NP; Dorf ME
J Immunol; 1997 Apr; 158(8):3561-4. PubMed ID: 9103415
[TBL] [Abstract][Full Text] [Related]
4. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
5. Identification of a major co-receptor for primary isolates of HIV-1.
Deng H; Liu R; Ellmeier W; Choe S; Unutmaz D; Burkhart M; Di Marzio P; Marmon S; Sutton RE; Hill CM; Davis CB; Peiper SC; Schall TJ; Littman DR; Landau NR
Nature; 1996 Jun; 381(6584):661-6. PubMed ID: 8649511
[TBL] [Abstract][Full Text] [Related]
6. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.
Zaitseva MB; Lee S; Rabin RL; Tiffany HL; Farber JM; Peden KW; Murphy PM; Golding H
J Immunol; 1998 Sep; 161(6):3103-13. PubMed ID: 9743377
[TBL] [Abstract][Full Text] [Related]
8. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
9. SDF-1-induced activation of ERK enhances HIV-1 expression.
Montes M; Tagieva NE; Heveker N; Nahmias C; Baleux F; Trautmann A
Eur Cytokine Netw; 2000 Sep; 11(3):470-7. PubMed ID: 11022134
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes.
Tanabe S; Heesen M; Yoshizawa I; Berman MA; Luo Y; Bleul CC; Springer TA; Okuda K; Gerard N; Dorf ME
J Immunol; 1997 Jul; 159(2):905-11. PubMed ID: 9218610
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
12. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
[TBL] [Abstract][Full Text] [Related]
13. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
15. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
Baba M; Takashima K; Miyake H; Kanzaki N; Teshima K; Wang X; Shiraishi M; Iizawa Y
Antimicrob Agents Chemother; 2005 Nov; 49(11):4584-91. PubMed ID: 16251299
[TBL] [Abstract][Full Text] [Related]
16. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
Margolis LB; Glushakova S; Grivel JC; Murphy PM
J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751
[TBL] [Abstract][Full Text] [Related]
17. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4.
D'Apuzzo M; Rolink A; Loetscher M; Hoxie JA; Clark-Lewis I; Melchers F; Baggiolini M; Moser B
Eur J Immunol; 1997 Jul; 27(7):1788-93. PubMed ID: 9247593
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 infection of Langerhans cells in a reconstructed vaginal mucosa.
Sivard P; Berlier W; Picard B; Sabido O; Genin C; Misery L
J Infect Dis; 2004 Jul; 190(2):227-35. PubMed ID: 15216455
[TBL] [Abstract][Full Text] [Related]
19. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
[TBL] [Abstract][Full Text] [Related]
20. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
Wu L; Gerard NP; Wyatt R; Choe H; Parolin C; Ruffing N; Borsetti A; Cardoso AA; Desjardin E; Newman W; Gerard C; Sodroski J
Nature; 1996 Nov; 384(6605):179-83. PubMed ID: 8906795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
